Z.-M. Yang et al.
2-Hydroxy[phenyl-3,4,5,6-3H4]benzldehyde (4)
carbonate (670.3 mg, 4.85 mmol) at 50À551C. The stirring was
continued for 48 h.5 The resulting mixture was filtered and
concentrated under vacuum. The residue was subjected to silica
gel flash chromatography (ethyl acetate/hexane 1:8À1:7) and
semipreparative HPLC (inject volume 200 mL; methanol/water
75:25, by vol.; flow rate 3.00 mL/min; detection UV 254.0nm;
column temperature 301C; the eluted liquid between
23.677À33.453 min were collected and concentrated) to afford
(7) (230.3mg, 39%). Radiochemical purity: 98.9%; chemical purity:
98.1%; specific activity: 4.896 mCi/mmol (determined by HPLC,5
Radio-TLC, and HLPC-LSC methods4). HPLC-MS (ESI) m/z: 424.3(M
1H1), 425.3(M1H111), 446.2(M1Na1). MS(EI, 70eV) m/z (%):
245(100), 423(M1, 62). 1H NMR (CDCl3, 300 MHz): 1.00(t, 3H,
J= 7.2 Hz, CH3), 1.74À1.75(m, 2H, J = 7.2Hz, J = 6.9Hz, CH2), 3.79(s,
6H, OCH3), 4.20(t, 2H, J = 6.9Hz, OCH2), 4.38(d, 2H, J = 5.6Hz,
NCH2), 4.67(t, J =5.4 Hz, 1H, NH), 5.77(s, 1H, CH), 6.49(d,2H,
J= 8.8 Hz, ArH), 7.15À7.40(m, 4H, HAr), 7.80(d, 2H, J = 8.8Hz,
ArH). The data were consistent with those in reference.9
To silica gel (2 g, 100À200 mesh) was added the solution
of [2,3,4,5,6-3H5]phenol in ethanol (10 mL, specific activity
5.00 mCi/mmol,
radioactive
concentration
1.00 mCi/mL)
and mixed. Ethanol was removed in vacuo under argon.
[2,3,4,5,6-3H5]phenol was eluted from silica gel with dry
acetone, followed by evaporation of acetone and dryness
over P2O5 to afford the starting material [2,3,4,5,6-3H5]
phenol (3).
To a dried Schlenck tube was added (3) (188.0 mg, 2.00mmol),
anhydrous magnesium dichloride (285.6 mg, 3.00 mmol), anhy-
drous triethylamine (727.5 mg, 7.19 mmol), and anhydrous acet-
onitrile (4 mL, refluxed for 30 min with CaH2), stirring under argon
at room temperature for 10 min. Paraformaldehyde (405.0 mg,
13.49 mmol) was added to the tube. The mixture was refluxed for
4 h and allowed to cool to room temperature.5,7 To the mixture
was added 10% HCl (5 mL), followed by extraction with ethyl
ether. The combined organic layers were washed with water and
saturated brine, dried over anhydrous MgCl2, and evaporated in
vacuo to afford (4) (229.3mg, 94%). GC-MS (EI, 70eV) m/z (%):
122(M1, 100). 1H NMR (CDCl3, 300 MHz) d: 6.98À7.06(m, 2H, ArH),
7.51À7.58(m, 2H, ArH), 9.90(s, 1H, OH), 11.04(s, 1H, CHO).
4,6-Dimethoxy-2-(methylthio)[4,6-14C2]pyrimidine (9)
To an accurately graduated flask (30.00 mL) equipped with a
condenser was added sodium (1.250 g, 54.35 mmol) and
anhydrous methanol (30 mL) at 0À51C in an ice bath under
argon. The mixture was stirred until it became clear, stirred for
another 10 min, and allowed to cool to room temperature. The
volume of the solution was increased to 30.00 mL by addition of
anhydrous methanol to the reaction mixture to afford the
solution of sodium methanolate (1.811 mmol/mL).
Propyl 4-(2-hydroxy[phenyl-3,4,5,6-3H4]benzylideneamino)-
benzoate (5)
To the stirred solution of propyl 4-aminobenzoate (336.9mg,
1.88mmol) in anhydrous methanol (2.5mL) was added (4)
(229.2mg, 1.88mmol) at 15À201C and the stirring was continued
for 1 h. The yellow precipitate formed immediately after ca.
30min. The precipitate was filtered off under vacuum, washed
with methanol (1.0mL, 0À51C), and then dried over P2O5 under
vacuum to afford (5) (425.3mg, 80%). MS (EI, 70eV) m/z
The resulting solution of sodium methanolate (2.76 mL,
5.0mmol) was added dropwise to the stirred solution of 4,6-
dichloro-2-(methylthio)[4,6-14C2]pyrimidine (8) (9.8mg, 0.05mmol,
specific activity 50 mCi/mmol), 4,6-dichloro-2-(methylthio)pyrimi-
dine (477.9mg, 2.45 mmol) and anhydrous methanol (10mL) in
Schlenck tube over 10 min and refluxed for 5 h.5,10 Water (10mL)
was added into the vigorously stirred reaction mixture, followed
by extraction with ethyl acetate. The combined organic layers
were washed with brine, dried over anhydrous Na2SO4, and
concentrated to afford (9) (437.6mg, 94%). HPLC-MS (ESI) m/z:
187(M1H1), 188(M1H111). MS (EI, 70eV) m/z (%): 186(M1, 100),
1
(%): 283(M1, 100), 240(47), 224(48). H NMR (CDCl3, 300 MHz) d:
1.05(t, J = 7.2 Hz, 3H, CH3), 1.82(m, J = 7.2 Hz, J = 6.9 Hz, 2H, CH2),
4.30(d, J = 6.9 Hz, 2H, OCH2), 6.94À6.99(m, 2H, ArH), 7.30(d,
J = 6.9 Hz, 2H, ArH), 7.39À7.43(m, 2H, ArH), 8.11(d, J = 6.9 Hz, 2H,
ArH), 8.63(s, 1H, HC= N).
Propyl 4-(2-hydroxy[phenyl-3,4,5,6-3H4]benzylamino)benzo-
ate (6)
1
171(20), 140(29), 125(26). H NMR (CDCl3, 300 MHz) d: 2.53(s, 3H,
SCH3), 3.92(s, 6H, OCH3), 5.71(s, 1H, CH).
Sodium borohydride (80 mg, 2.11mmol) was added in portions to
the vigorously stirred suspension of (5) (424.0mg, 1.50mmol) in
anhydrous methanol (4 mL) at 0À51C. The mixture was stirred for
30min. To the resulting solution was added water (8mL) then
stirred for another 30min. The solution was concentrated in
vacuo to remove methanol and extracted with ethyl acetate. The
combined organic layers were washed with saturated brine, dried
over anhydrous Na2SO4, and evaporated under reduced pressure
to afford (6) (396.1 mg, 93%). HPLC-MS (ESI) m/z: 286(M1H1),
287(M1H111). MS (EI, 70eV) m/z (%): 285(M1, 46), 137(100),
179(36), 120(62), 107(55). 1H NMR (CD3SOCD3, 300 MHz) d: 0.93(t,
J = 7.2 Hz, 3H, CH3), 1.65(m, J = 7.2 Hz, J = 6.9 Hz, 2H, CH2), 4.11(t,
J = 6.9 Hz, 2H, OCH2), 4.30(s, 2H, NCH), 6.65(t, J = 8.7 Hz, 2H, ArH),
6.66À7.18(m, 4H, ArH), 7.72(t, J = 8.7 Hz, 2H, ArH), 9.76(s, 1H, OH).
4,6-Dimethoxy-2-(methylsulfonyl)[4,6-14C2]pyrimidine (10)
To a stirred solution of (9) (436.8 mg, 2.35 mmol) and sodium
tungstate dihydrate (40.0 mg, 0.12 mmol) in acetic acid (2 mL)
was added 30% hydrogen peroxide (0.50 mL, 4.90 mmol) at
401C. The solution was stirred for 10 min, allowed to warm to
501C, and stirred for 4 h.5,10 The mixture was cooled to room
temperature and evaporated acetic acid in vacuum. The residue
was suspended in ethyl acetate (8 mL), washed with water,
concentrated, and subjected to flash chromatograph (ethyl
acetate/hexane 1:4) to afford (10) (429.9 mg, 84%). HPLC-MS
(ESI) m/z: 219(M1H1), 220(M1H111). MS (EI, 70 eV) m/z (%):
218(M1, 28), 139(100). 1H NMR (CDCl3, 300 MHz) d: 3.32(s, 3H,
SCH3), 4.03(s, 6H, OCH3), 6.18(s, 1H, CH).
Propyl
4-(2-(4,6-dimethoxypyrimidin-2-yloxy)[phenyl-
3,4,5,6-3H4]benzylamino) benzoate (7)
Propyl 4-(2-(4,6-dimethoxy[4,6-14C2]pyrimidin-2-yloxy)ben-
zylamino)benzoate (12)
To the vigorously stirred solution of (6) (395.4mg, 1.39 mmol) and
4,6-dimethoxy-2-(methylsulfonyl)pyrimidine (302.4mg, 1.39 mmol)
A mixture of anhydrous potassium carbonate (812.7 mg,
in anhydrous acetonitrile (5 mL) was added anhydrous potassium 5.88 mmol), propyl 4-(2-hydroxybenzylamino)benzoate (11)
J. Label Compd. Radiopharm 2008, 51 182–186
Copyright r 2008 John Wiley & Sons, Ltd.